Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 596797, 7 pages
http://dx.doi.org/10.1155/2015/596797
Clinical Study

Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4–10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD Score

1Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, National Urological Cancer Center, No. 8 Xishiku Street, Xicheng District, Beijing 100034, China
2Department of Radiology, Peking University First Hospital, No. 8 Xishiku Street, Xicheng District, Beijing 100034, China

Received 4 May 2015; Revised 1 August 2015; Accepted 9 August 2015

Academic Editor: Charnita M. Zeigler-Johnson

Copyright © 2015 Dong Fang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Heidenreich, P. J. Bastian, J. Bellmunt et al., “EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013,” European Urology, vol. 65, no. 1, pp. 124–137, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Perdonà, G. Di Lorenzo, R. Autorino et al., “Combined magnetic resonance spectroscopy and dynamic contrast-enhanced imaging for prostate cancer detection,” Urologic Oncology, vol. 31, no. 6, pp. 761–765, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. J. H. Yacoub, A. Oto, and F. H. Miller, “MR imaging of the prostate,” Radiologic Clinics of North America, vol. 52, no. 4, pp. 811–837, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Turkbey, H. Mani, V. Shah et al., “Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds,” Journal of Urology, vol. 186, no. 5, pp. 1818–1824, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Thompson, N. Lawrentschuk, M. Frydenberg, L. Thompson, and P. Stricker, “The role of magnetic resonance imaging in the diagnosis and management of prostate cancer,” BJU International, vol. 112, supplement 2, pp. 6–20, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. H. G. Welch, L. M. Schwartz, and S. Woloshin, “Prostate-specific antigen levels in the United States: implications of various definitions for abnormal,” Journal of the National Cancer Institute, vol. 97, no. 15, pp. 1132–1137, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. O. M. Zaytoun, M. W. Kattan, A. S. Moussa, J. Li, C. Yu, and J. S. Jones, “Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information,” Urology, vol. 78, no. 2, pp. 392–398, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. I. G. Jeong, J. H. Lim, S. C. Kim et al., “Nomogram using transrectal ultrasound-derived information predicting the detection of high grade prostate cancer on initial biopsy,” Prostate International, vol. 1, no. 2, pp. 69–75, 2013. View at Publisher · View at Google Scholar
  9. K. Kawamura, H. Suzuki, N. Kamiya et al., “Development of a new nomogram for predicting the probability of a positive initial prostate biopsy in Japanese patients with serum PSA levels less than 10 ng/mL,” International Journal of Urology, vol. 15, no. 7, pp. 598–603, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. W. J. Catalona, A. W. Partin, K. M. Slawin et al., “Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial,” Journal of the American Medical Association, vol. 279, no. 19, pp. 1542–1547, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Hu, Q. Zhao, J. Rao, H. Deng, H. Yuan, and B. Xu, “Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: a retrospective population-based cohort study, 2000–2009,” BMC Public Health, vol. 14, article 356, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Chen, R. Zheng, H. Zeng, S. Zhang, and J. He, “Annual report on status of cancer in China, 2011,” Chinese Journal of Cancer Research, vol. 27, no. 1, pp. 2–12, 2015. View at Google Scholar
  13. J. Y. Teoh, S. K. Yuen, J. H. Tsu et al., “Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?” Asian Journal of Andrology, 2015. View at Publisher · View at Google Scholar
  14. W. K. W. So, K. C. Choi, W. P. Y. Tang et al., “Uptake of prostate cancer screening and associated factors among Chinese men aged 50 or more: a population-based survey,” Cancer Biology & Medicine, vol. 11, no. 1, pp. 56–63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. B. G. Muller, J. H. Shih, S. Sankineni et al., “Prostate cancer: interobserver agreement and accuracy with the revised prostate imaging reporting and data system at multiparametric MR imaging,” Radiology, 2015. View at Publisher · View at Google Scholar
  16. G. L. Andriole, E. D. Crawford, R. L. Grubb III et al., “Mortality results from a randomized prostate-cancer screening trial,” The New England Journal of Medicine, vol. 360, no. 13, pp. 1310–1319, 2009. View at Google Scholar
  17. F. H. Schröder, J. Hugosson, M. J. Roobol et al., “Screening and prostate-cancer mortality in a randomized european study,” The New England Journal of Medicine, vol. 360, no. 13, pp. 1320–1328, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Kuligowska, M. A. Barish, H. M. Fenlon, and M. Blake, “Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers,” Radiology, vol. 220, no. 3, pp. 757–764, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. E. J. Halpern and S. E. Strup, “Using gray-scale and color and power Doppler sonography to detect prostatic cancer,” American Journal of Roentgenology, vol. 174, no. 3, pp. 623–627, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. F. K.-H. Chun, A. Briganti, M. Graefen et al., “Development and external validation of an extended 10-core biopsy nomogram,” European Urology, vol. 52, no. 2, pp. 436–445, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. P. I. Karakiewicz, S. Benayoun, M. W. Kattan et al., “Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen,” Journal of Urology, vol. 173, no. 6, pp. 1930–1934, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Q. Na, Z. Q. Ye, Y. H. Sun et al., “Guideline on diagnosis and treatment of prostate cancer,” in 2014 Chinese Urological Association Guidelines, p. 63, People's Health Publishing House, Beijing, China, 2014. View at Google Scholar
  23. I. G. Jeong and K. H. Lee, “Percent free prostate specific antigen does not enhance the specificity of total prostate specific antigen for the detection of prostate cancer in Korean men 50 to 65 years old: a prospective multicenter study,” Journal of Urology, vol. 179, no. 1, pp. 111–116, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. H. B. Carter, P. C. Albertsen, M. J. Barry et al., “Early detection of prostate cancer: AUA guideline,” The Journal of Urology, vol. 190, no. 2, pp. 419–426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. J. O. Barentsz, J. Richenberg, R. Clements et al., “ESUR prostate MR guidelines 2012,” European Radiology, vol. 22, no. 4, pp. 746–757, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Haffner, L. Lemaitre, P. Puech et al., “Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection,” BJU International, vol. 108, no. 8, part 2, pp. E171–E178, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. B. K. Park, J. W. Park, S. Y. Park et al., “Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy,” American Journal of Roentgenology, vol. 197, no. 5, pp. W876–W881, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. N. K. Yerram, D. Volkin, B. Turkbey et al., “Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer,” BJU International, vol. 110, no. 11, pp. E783–E788, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. I. G. Schoots, M. J. Roobol, D. Nieboer, C. Bangma, E. Steyerberg, and M. Hunink, “Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis,” European Urology, 2014. View at Publisher · View at Google Scholar
  30. L. Marks, S. Young, and S. Natarajan, “MRI-ultrasound fusion for guidance of targeted prostate biopsy,” Current Opinion in Urology, vol. 23, no. 1, pp. 43–50, 2013. View at Publisher · View at Google Scholar · View at Scopus